Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

SOCS3 Phosphorylation In Myeloproliferative Neoplasms

Claire Arnold, MB, BCh, Joanne Elliott, PhD, James A Johnston, PhD, Mary Frances McMullin, MD

Blood (2010) 116 (21): 3083.

https://doi.org/10.1182/blood.V116.21.3083.3083

Published: 2010

Journal Articles

The myeloproliferative disorder–associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3

Michelle B. Hookham, Joanne Elliott, Yvonne Suessmuth, Judith Staerk, Alister C. Ward, William Vainchenker, Melanie J. Percy, Mary Frances McMullin, Stefan N. Constantinescu, James A. Johnston

Blood (2007) 109 (11): 4924–4929.

https://doi.org/10.1182/blood-2006-08-039735

Published: 2007

Includes: Supplemental data

Journal Articles

CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover

Selinda J. Orr, Nuala M. Morgan, Joanne Elliott, James F. Burrows, Christopher J. Scott, Daniel W. McVicar, James A. Johnston

Blood (2006) 109 (3): 1061–1068.

https://doi.org/10.1182/blood-2006-05-023556

Published: 2006

Journal Articles

The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawal

Thi-Sau Migone, Martine Humbert, Anne Rascle, David Sanden, Alan D'Andrea, James A. Johnston

Blood (2001) 98 (6): 1935–1941.

https://doi.org/10.1182/blood.V98.6.1935

Published: 2001

Journal Articles

Structural and Functional Basis for JAK3-Deficient Severe Combined Immunodeficiency

Fabio Candotti, Scott A. Oakes, James A. Johnston, Silvia Giliani, Richard F. Schumacher, Patrizia Mella, Maurilia Fiorini, Alberto G. Ugazio, Raffaele Badolato, Luigi D. Notarangelo, Fabio Bozzi, Paolo Macchi, Dario Strina, Paolo Vezzoni, R. Michael Blaese, John J. O'Shea, Anna Villa

Blood (1997) 90 (10): 3996–4003.

https://doi.org/10.1182/blood.V90.10.3996

Published: 1997

NARROW

SOCS3 Phosphorylation In Myeloproliferative Neoplasms

The myeloproliferative disorder–associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3

CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover

The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawal

Structural and Functional Basis for JAK3-Deficient Severe Combined Immunodeficiency

Email alerts

ASH Publications

American Society of Hematology

SOCS3 Phosphorylation In Myeloproliferative Neoplasms

The myeloproliferative disorder–associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3

CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover

The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawal

Structural and Functional Basis for JAK3-Deficient Severe Combined Immunodeficiency

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only